GxPinnacle Logo
Skip to content

What Do Inspectors Check for Document Creation, Numbering and Templates in Pharmacovigilance?

Pharmacovigilance documents must be created using controlled templates, structured numbering systems, and defined authorship processes. Regulators expect consistency, traceability, and standardisation from document creation onwards.

For: Founders, CEOs & MDs·PV Leads·QA/Compliance·Scientists tasked with documentation

Alignment: Global pharmacovigilance principles (ICH-aligned) and inspection practices

Most useful when: Preparing for inspection, setting up a process, or closing a documentation gap

Key points

  • Pharmacovigilance documents must be created using defined templates and structured formats.
  • Document numbering systems must ensure traceability, version control, and identification.
  • Authorship and ownership must be clearly assigned during document creation.
  • Templates must standardise content, structure, and formatting across all PV documents.
  • Document creation must align with regulatory requirements and operational processes.
  • Inspection-ready evidence must demonstrate that document creation is controlled, consistent, and traceable from the outset.

What inspectors expect

Each point below should be supported by controlled documents and traceable records.

  • Documents must be created using controlled templates.
  • Document numbering must ensure traceability and identification.
  • Authorship and ownership must be clearly defined.
  • Templates must ensure consistency across documentation.
  • Document creation must align with PV processes and regulatory expectations.

Summary

Inspectors assess whether pharmacovigilance documents are created using controlled templates, structured numbering systems, and defined authorship. They review document consistency, traceability, and whether templates ensure standardised and compliant documentation across the PV system.

Common questions

These are the questions this page is designed to answer directly.

  • How are pharmacovigilance documents created?
  • What do inspectors check for document creation in PV?
  • How should SOPs be structured in pharmacovigilance?
  • What is document numbering in pharmacovigilance?
  • What templates are required for PV documentation?
  • How do you standardise pharmacovigilance documents?
  • What is a document control template?
  • How do regulators assess document creation processes?
  • What is required when creating SOPs in pharmacovigilance?
  • How do you ensure consistency in PV documentation?

Evidence objects inspectors expect

Controlled Document Templates

  • Standard SOP template with predefined structure
  • Work instruction templates for operational processes
  • Consistent section headings, formatting, and document layout
  • Defined document headers including version, ID, and approval fields

Document Numbering System

  • Unique document identifiers
  • Standardised naming conventions
  • Link between document number, type, and function
  • Traceability across versions and document lifecycle

Document Creation and Authorship Records

  • Document author identification
  • Defined document owner responsibilities
  • Draft creation records
  • Evidence of initial document development process

Template Governance and Standardisation

  • Controlled templates maintained within document system
  • Consistency across SOPs, work instructions, and forms
  • Defined formatting and structure requirements
  • Template version control

Initial Document Review Preparation

  • Prepared draft documents ready for review
  • Alignment with PV processes and regulatory expectations
  • Document completeness before formal approval
  • Evidence of structured content development

Regulatory Basis (Primary Sources)

  • GVP Module I – requirement for structured quality system documentation
  • GVP Module II – pharmacovigilance system documentation requirements
  • ICH E2D – requirement for consistent and controlled documentation processes
  • MHRA GPvP guidance – expectations for structured documentation
  • FDA 21 CFR Part 11 – requirements for controlled electronic documentation

Typical Inspection Questions (What Inspectors Ask)

  • How are pharmacovigilance documents created?
  • What templates do you use for SOPs and work instructions?
  • How are documents numbered and identified?
  • How do you ensure consistency across documents?
  • Who is responsible for creating and owning documents?

Failure patterns

Documents are created without using controlled templates.

Document numbering is inconsistent or missing.

Documents lack defined ownership or authorship.

Inconsistent formatting and structure across documents.

Templates are not controlled or updated.

What good looks like

  • Use of standardised templates for all PV documents.
  • Clear and consistent document numbering system.
  • Defined authorship and ownership for each document.
  • Consistent structure and formatting across documentation.
  • Controlled template management supporting document consistency.

Operationalisation

  • Define standard templates for SOPs, work instructions, and forms.
  • Implement a structured document numbering system.
  • Assign document owners and authors during creation.
  • Ensure all documents follow consistent formatting and structure.
  • Maintain control of templates within the document management system.
  • Align document creation with PV processes and regulatory requirements.

Need regulatory documentation today?

Save time and reduce inspection risk with structured, pre-built process-ready documentation.
Created by industry professionals, adaptable to your organisation.

Related pre-built documentation inside the app

Get AccessLog In

FAQ

How are pharmacovigilance documents created?

Pharmacovigilance documents are created using controlled templates, defined authorship, and structured processes to ensure consistency, traceability, and compliance.

What is document numbering in pharmacovigilance?

Document numbering is a structured system that assigns unique identifiers to each document to ensure traceability, version control, and easy identification.

What templates are used in pharmacovigilance documentation?

Templates typically include SOP templates, work instruction templates, forms, and controlled document formats that standardise structure and content.

What is a document template in pharmacovigilance?

A document template is a predefined format used to create consistent and compliant documents, ensuring that all required sections, structure, and metadata are included.

Why is standardisation important in document creation?

Standardisation ensures consistency, reduces errors, supports compliance, and makes documents easier to review, audit, and maintain.

What do inspectors check for document creation?

Inspectors check whether documents are created using controlled templates, numbered correctly, owned by defined roles, and consistent across the pharmacovigilance system.

Sources

Primary guidance used to inform this map. This page is a structured interpretation layer; always validate against the original source documents.

European Medicines Agency (EMA)

  • Guideline on good pharmacovigilance practices (GVP) – Module I
    View source
  • Guideline on good pharmacovigilance practices (GVP) – Module II
    View source

FDA

ICH

MHRA